This inventor holds 1 USPTO granted patent. Top assignee: Polaris Pharmaceuticals, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Yu-De Chu: Innovator in Arginine Deprivation Therapy
Introduction
Yu-De Chu is a prominent inventor based in Taoyuan, Taiwan. He has made significant contributions to the field of medical research, particularly in the area of cancer therapy. His innovative work focuses on methods and kits that identify subjects responsive to arginine deprivation therapy.
Latest Patents
Yu-De Chu holds a patent titled "Methods and Kits for Identifying Subjects Responsive to Arginine Deprivation Therapy." This patent represents a crucial advancement in personalized medicine, allowing for more effective treatment strategies for patients.
Career Highlights
Currently, Yu-De Chu is affiliated with Polaris Pharmaceuticals, Inc., where he continues to develop groundbreaking therapies. His work has garnered attention for its potential to improve patient outcomes in cancer treatment.
Collaborations
Yu-De Chu collaborates with esteemed colleagues, including Hui-Fen Liu and Hung-Wen Chen. Together, they contribute to the advancement of medical research and innovation.
Conclusion
In summary, Yu-De Chu is a dedicated inventor whose work in arginine deprivation therapy is paving the way for new treatment options in oncology. His contributions are vital to the ongoing evolution of personalized medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile